Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.
Human papillomavirus (HPV) infection, particularly type 16, is causally associated with the development of cervical cancer. The E6 and E7 proteins of HPV are constitutively expressed in cervical carcinoma cells making them attractive targets for CTL-based immunotherapy. However, few studies have add...
Hlavní autoři: | Evans, M, Borysiewicz, L, Evans, A, Rowe, M, Jones, M, Gileadi, U, Cerundolo, V, Man, S |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2001
|
Podobné jednotky
-
Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.
Autor: Youde, S, a další
Vydáno: (2000) -
Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
Autor: Gileadi, U, a další
Vydáno: (1999) -
Human papillomavirus type 16 in vulvar carcinoma, vulvar intraepithelial neoplasia, and associated cervical neoplasia.
Autor: Hørding, U, a další
Vydáno: (1991) -
Role of the proteasome and non proteasomal proteases in the generation of CTL epitopes.
Autor: Cerundolo, V, a další
Vydáno: (1998) -
Human papillomavirus and cervical cancer.
Autor: Jensen, O, a další
Vydáno: (1988)